ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Teicoplanin
  • indication:For the treatment of bacterial infections caused by susceptible microorganisms.
  • pharmacologypharmacology:
  • mechanism: Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death.
  • toxicity:
  • absorprion: Teicoplanin is poorly absorbed after oral administration but is 90% bioavailable when administered intramuscularly.
  • halflife: 70-100 hours
  • roouteelimination:
  • volumedistribution:
  • clearance: